Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Use Surveillance for ADCETRIS Intravenous Infusion "Untreated CD30-Positive Hodgkin's Lymphoma"

NCT03729609 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT03729609
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03729609 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Use Surveillance for ADCETRIS Intravenous Infusion "Untreated CD30-Positive Hodgkin's Lymphoma"
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
November 1, 2018
Completion date
September 27, 2023
Enrollment
113 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

untreated cd30-positive hodgkin's lymphoma